chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Atrial fibrillation, Blood creatinine increased, Blood thyroid stimulating hormone abnormal
Clinical narrative: Patient is a 83 y.o. female with history of fib, HFpEF, CAD s/p CABG, COPD, OSA, HTN, HLD, DM2, presented to the hospital with dyspnea found to have hypoxia .   Acute on chronic respiratory failure with hypoxia Normally requiring only 2L nocturnal. Initially presenting with hypoxia requiring 3 L. Etiology secondary to COVID. Treating as per below. CT reviewed and without edema or fluid level. Wean O2 as tolerated. 2/1: Currently stable on room air.  Stable for discharge and to complete course of dexamethasone.   Covid-19 Virus Infection Date of onset of symptoms: 1/28/2023 Symptoms present on admission: Cough, nausea, dyspnea Date of covid positive test: 1/30/2023 Vaccination status: vaccinated Imaging: CXR, CT PE Oxygen requirements on admission: 3 L Current oxygen requirements: Room air Medical therapy: steroids.  Holding remdesivir against AKI. Consultants following: N/A Anticipated special isolation end date: 2/8/2023 2/1: Clinically stable on room air, discharge to complete 10-day course of dexamethasone.   Chronic HFpEF Recent admitted to other hospital from 1/18 through 1/22/2023. Diarrhea significantly at that time. Euvolemic on this admission. Most recent echo 3/2022 with EF 63%, RV systolic function mildly reduced  Holding lisinopril and Lasix against AKI. Resume home metoprolol and sotalol. Follows with Dr. as outpatient We will follow clinically.  2/1: Remains euvolemic, and the patient has significant decompensation admission earlier in the month we will cut Lasix down to 40 mg twice daily.   AKI On recent admission Lasix was augmented to 80 mg twice daily. Holding as creatinine has risen to 1.50. 2/1: Continues to improve to 1.47. With history of HFpEF we will cut Lasix down to 40 mg twice daily upon discharge.  To follow-up with cardiology as outpatient. Repeat labs in 1 week.   Abnormal TSH TSH 4.34, recheck normal   Atrial fibrillation EKG with sinus rhythm Continue home metoprolol, apixaban  Sotalol on hold until reevaluation by cardiology.   Chronic normocytic anemia Baseline hemoglobin 9?10 At baseline
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cardiac failure, Cardiac failure chronic, Chest X-ray, Computerised tomogram normal
Clinical narrative: Patient is a 83 y.o. female with history of fib, HFpEF, CAD s/p CABG, COPD, OSA, HTN, HLD, DM2, presented to the hospital with dyspnea found to have hypoxia .   Acute on chronic respiratory failure with hypoxia Normally requiring only 2L nocturnal. Initially presenting with hypoxia requiring 3 L. Etiology secondary to COVID. Treating as per below. CT reviewed and without edema or fluid level. Wean O2 as tolerated. 2/1: Currently stable on room air.  Stable for discharge and to complete course of dexamethasone.   Covid-19 Virus Infection Date of onset of symptoms: 1/28/2023 Symptoms present on admission: Cough, nausea, dyspnea Date of covid positive test: 1/30/2023 Vaccination status: vaccinated Imaging: CXR, CT PE Oxygen requirements on admission: 3 L Current oxygen requirements: Room air Medical therapy: steroids.  Holding remdesivir against AKI. Consultants following: N/A Anticipated special isolation end date: 2/8/2023 2/1: Clinically stable on room air, discharge to complete 10-day course of dexamethasone.   Chronic HFpEF Recent admitted to other hospital from 1/18 through 1/22/2023. Diarrhea significantly at that time. Euvolemic on this admission. Most recent echo 3/2022 with EF 63%, RV systolic function mildly reduced  Holding lisinopril and Lasix against AKI. Resume home metoprolol and sotalol. Follows with Dr. as outpatient We will follow clinically.  2/1: Remains euvolemic, and the patient has significant decompensation admission earlier in the month we will cut Lasix down to 40 mg twice daily.   AKI On recent admission Lasix was augmented to 80 mg twice daily. Holding as creatinine has risen to 1.50. 2/1: Continues to improve to 1.47. With history of HFpEF we will cut Lasix down to 40 mg twice daily upon discharge.  To follow-up with cardiology as outpatient. Repeat labs in 1 week.   Abnormal TSH TSH 4.34, recheck normal   Atrial fibrillation EKG with sinus rhythm Continue home metoprolol, apixaban  Sotalol on hold until reevaluation by cardiology.   Chronic normocytic anemia Baseline hemoglobin 9?10 At baseline
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Condition aggravated, Cough, Diarrhoea, Dyspnoea, Echocardiogram abnormal
Clinical narrative: Patient is a 83 y.o. female with history of fib, HFpEF, CAD s/p CABG, COPD, OSA, HTN, HLD, DM2, presented to the hospital with dyspnea found to have hypoxia .   Acute on chronic respiratory failure with hypoxia Normally requiring only 2L nocturnal. Initially presenting with hypoxia requiring 3 L. Etiology secondary to COVID. Treating as per below. CT reviewed and without edema or fluid level. Wean O2 as tolerated. 2/1: Currently stable on room air.  Stable for discharge and to complete course of dexamethasone.   Covid-19 Virus Infection Date of onset of symptoms: 1/28/2023 Symptoms present on admission: Cough, nausea, dyspnea Date of covid positive test: 1/30/2023 Vaccination status: vaccinated Imaging: CXR, CT PE Oxygen requirements on admission: 3 L Current oxygen requirements: Room air Medical therapy: steroids.  Holding remdesivir against AKI. Consultants following: N/A Anticipated special isolation end date: 2/8/2023 2/1: Clinically stable on room air, discharge to complete 10-day course of dexamethasone.   Chronic HFpEF Recent admitted to other hospital from 1/18 through 1/22/2023. Diarrhea significantly at that time. Euvolemic on this admission. Most recent echo 3/2022 with EF 63%, RV systolic function mildly reduced  Holding lisinopril and Lasix against AKI. Resume home metoprolol and sotalol. Follows with Dr. as outpatient We will follow clinically.  2/1: Remains euvolemic, and the patient has significant decompensation admission earlier in the month we will cut Lasix down to 40 mg twice daily.   AKI On recent admission Lasix was augmented to 80 mg twice daily. Holding as creatinine has risen to 1.50. 2/1: Continues to improve to 1.47. With history of HFpEF we will cut Lasix down to 40 mg twice daily upon discharge.  To follow-up with cardiology as outpatient. Repeat labs in 1 week.   Abnormal TSH TSH 4.34, recheck normal   Atrial fibrillation EKG with sinus rhythm Continue home metoprolol, apixaban  Sotalol on hold until reevaluation by cardiology.   Chronic normocytic anemia Baseline hemoglobin 9?10 At baseline
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Electrocardiogram, Haemoglobin decreased, Hypoxia, Nausea, Normocytic anaemia
Clinical narrative: Patient is a 83 y.o. female with history of fib, HFpEF, CAD s/p CABG, COPD, OSA, HTN, HLD, DM2, presented to the hospital with dyspnea found to have hypoxia .   Acute on chronic respiratory failure with hypoxia Normally requiring only 2L nocturnal. Initially presenting with hypoxia requiring 3 L. Etiology secondary to COVID. Treating as per below. CT reviewed and without edema or fluid level. Wean O2 as tolerated. 2/1: Currently stable on room air.  Stable for discharge and to complete course of dexamethasone.   Covid-19 Virus Infection Date of onset of symptoms: 1/28/2023 Symptoms present on admission: Cough, nausea, dyspnea Date of covid positive test: 1/30/2023 Vaccination status: vaccinated Imaging: CXR, CT PE Oxygen requirements on admission: 3 L Current oxygen requirements: Room air Medical therapy: steroids.  Holding remdesivir against AKI. Consultants following: N/A Anticipated special isolation end date: 2/8/2023 2/1: Clinically stable on room air, discharge to complete 10-day course of dexamethasone.   Chronic HFpEF Recent admitted to other hospital from 1/18 through 1/22/2023. Diarrhea significantly at that time. Euvolemic on this admission. Most recent echo 3/2022 with EF 63%, RV systolic function mildly reduced  Holding lisinopril and Lasix against AKI. Resume home metoprolol and sotalol. Follows with Dr. as outpatient We will follow clinically.  2/1: Remains euvolemic, and the patient has significant decompensation admission earlier in the month we will cut Lasix down to 40 mg twice daily.   AKI On recent admission Lasix was augmented to 80 mg twice daily. Holding as creatinine has risen to 1.50. 2/1: Continues to improve to 1.47. With history of HFpEF we will cut Lasix down to 40 mg twice daily upon discharge.  To follow-up with cardiology as outpatient. Repeat labs in 1 week.   Abnormal TSH TSH 4.34, recheck normal   Atrial fibrillation EKG with sinus rhythm Continue home metoprolol, apixaban  Sotalol on hold until reevaluation by cardiology.   Chronic normocytic anemia Baseline hemoglobin 9?10 At baseline
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory failure, Right ventricular dysfunction, SARS-CoV-2 test positive, Sinus rhythm, Systolic dysfunction
Clinical narrative: Patient is a 83 y.o. female with history of fib, HFpEF, CAD s/p CABG, COPD, OSA, HTN, HLD, DM2, presented to the hospital with dyspnea found to have hypoxia .   Acute on chronic respiratory failure with hypoxia Normally requiring only 2L nocturnal. Initially presenting with hypoxia requiring 3 L. Etiology secondary to COVID. Treating as per below. CT reviewed and without edema or fluid level. Wean O2 as tolerated. 2/1: Currently stable on room air.  Stable for discharge and to complete course of dexamethasone.   Covid-19 Virus Infection Date of onset of symptoms: 1/28/2023 Symptoms present on admission: Cough, nausea, dyspnea Date of covid positive test: 1/30/2023 Vaccination status: vaccinated Imaging: CXR, CT PE Oxygen requirements on admission: 3 L Current oxygen requirements: Room air Medical therapy: steroids.  Holding remdesivir against AKI. Consultants following: N/A Anticipated special isolation end date: 2/8/2023 2/1: Clinically stable on room air, discharge to complete 10-day course of dexamethasone.   Chronic HFpEF Recent admitted to other hospital from 1/18 through 1/22/2023. Diarrhea significantly at that time. Euvolemic on this admission. Most recent echo 3/2022 with EF 63%, RV systolic function mildly reduced  Holding lisinopril and Lasix against AKI. Resume home metoprolol and sotalol. Follows with Dr. as outpatient We will follow clinically.  2/1: Remains euvolemic, and the patient has significant decompensation admission earlier in the month we will cut Lasix down to 40 mg twice daily.   AKI On recent admission Lasix was augmented to 80 mg twice daily. Holding as creatinine has risen to 1.50. 2/1: Continues to improve to 1.47. With history of HFpEF we will cut Lasix down to 40 mg twice daily upon discharge.  To follow-up with cardiology as outpatient. Repeat labs in 1 week.   Abnormal TSH TSH 4.34, recheck normal   Atrial fibrillation EKG with sinus rhythm Continue home metoprolol, apixaban  Sotalol on hold until reevaluation by cardiology.   Chronic normocytic anemia Baseline hemoglobin 9?10 At baseline
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Injection site swelling
Clinical narrative: Site: Swelling at Injection Site-Mild, Additional Details: Patient states she noticed redness in the interior area of her arm, close to her axilla area, not on her deltoid where the vaccine was administered. Patient was concerned since this occurred 2 days after her Tdap vaccine
Age: 30.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, Product storage error
Clinical narrative: The COVID booster was left out overnight and 2 patients were given  expired COVID boosters.
Age: 25.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Chills-Mild, Systemic: Fever-Medium, Systemic: Lymph Node Swelling-Mild
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Systemic: Nausea-Severe, Systemic: Vomiting-Severe
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injury associated with device
Clinical narrative: Error: Patient Accidentally Stuck by Needle-
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, Product storage error
Clinical narrative: COVID booster was left out overnight and 2 patients were given  expired COVID boosters
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: Pt was accidentally given Moderna Primary Dose for 12+ and not 5-11 years of age
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pfizer-Biontech Covid-19 Bivalent vaccine was administered for first primary dose instead of the Pfizer-Biontech Covid-19 Monovalent vaccine
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Asthenia, Blood creatinine normal, Blood thyroid stimulating hormone decreased
Clinical narrative: Patient is a 79 y.o. female patient of local MD with history of COPD, hypothyroidism, chronic pain syndrome, essential hypertension, hyperlipidemia presented to ED with shortness of breath.  Found to have COVID-19 infection with acute hypoxic respiratory failure and AKI .  Patient transferred to Doctors Hospital for further medical care.   Covid-19 Virus Infection Acute hypoxic respiratory failure Acute COPD exacerbation Date of onset of symptoms: 1-2 days Symptoms present on admission: URI symptoms including cough, shortness of breath Date of covid positive test: 02/7/23 Vaccination status: vaccinated Imaging: Chest x-ray with bibasilar opacities Oxygen requirements on admission: 2L  Current oxygen requirements: 2L Medical therapy: dexamethasone Consultants following: None Anticipated special isolation end date: 02/16/23 Hypoxia has resolved, pt is stable for discharge     AKI 1.45 on admission at hospital Received IV fluid hydration, AKI resolved, Cr .75   Sinus bradycardia HR in 39-84, sinus rhythm, TTE: EF 55% Mostly asymptomatic, but states she did have syncopal episode < 3 mn ago Cardiology consulted, sinus brady has been present for several yrs Pt is stable for discharge      Generalized weakness In the setting of above Consult PT/OT   Essential hypertension On amlodipine, losartan and hydrochlorothiazide Cont current home medications   Hypothyroidism Continue Synthroid, TSH .47    Chronic pain syndrome NARx reviewed Continue hydrocodone/acetaminophen  Hyperlipidemia Continue statins   Depression Continue Lexapro   GERD Continue PPI
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chest X-ray abnormal, Chronic obstructive pulmonary disease, Condition aggravated, Cough
Clinical narrative: Patient is a 79 y.o. female patient of local MD with history of COPD, hypothyroidism, chronic pain syndrome, essential hypertension, hyperlipidemia presented to ED with shortness of breath.  Found to have COVID-19 infection with acute hypoxic respiratory failure and AKI .  Patient transferred to Doctors Hospital for further medical care.   Covid-19 Virus Infection Acute hypoxic respiratory failure Acute COPD exacerbation Date of onset of symptoms: 1-2 days Symptoms present on admission: URI symptoms including cough, shortness of breath Date of covid positive test: 02/7/23 Vaccination status: vaccinated Imaging: Chest x-ray with bibasilar opacities Oxygen requirements on admission: 2L  Current oxygen requirements: 2L Medical therapy: dexamethasone Consultants following: None Anticipated special isolation end date: 02/16/23 Hypoxia has resolved, pt is stable for discharge     AKI 1.45 on admission at hospital Received IV fluid hydration, AKI resolved, Cr .75   Sinus bradycardia HR in 39-84, sinus rhythm, TTE: EF 55% Mostly asymptomatic, but states she did have syncopal episode < 3 mn ago Cardiology consulted, sinus brady has been present for several yrs Pt is stable for discharge      Generalized weakness In the setting of above Consult PT/OT   Essential hypertension On amlodipine, losartan and hydrochlorothiazide Cont current home medications   Hypothyroidism Continue Synthroid, TSH .47    Chronic pain syndrome NARx reviewed Continue hydrocodone/acetaminophen  Hyperlipidemia Continue statins   Depression Continue Lexapro   GERD Continue PPI
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Echocardiogram, Ejection fraction normal, Lung opacity, Respiratory symptom
Clinical narrative: Patient is a 79 y.o. female patient of local MD with history of COPD, hypothyroidism, chronic pain syndrome, essential hypertension, hyperlipidemia presented to ED with shortness of breath.  Found to have COVID-19 infection with acute hypoxic respiratory failure and AKI .  Patient transferred to Doctors Hospital for further medical care.   Covid-19 Virus Infection Acute hypoxic respiratory failure Acute COPD exacerbation Date of onset of symptoms: 1-2 days Symptoms present on admission: URI symptoms including cough, shortness of breath Date of covid positive test: 02/7/23 Vaccination status: vaccinated Imaging: Chest x-ray with bibasilar opacities Oxygen requirements on admission: 2L  Current oxygen requirements: 2L Medical therapy: dexamethasone Consultants following: None Anticipated special isolation end date: 02/16/23 Hypoxia has resolved, pt is stable for discharge     AKI 1.45 on admission at hospital Received IV fluid hydration, AKI resolved, Cr .75   Sinus bradycardia HR in 39-84, sinus rhythm, TTE: EF 55% Mostly asymptomatic, but states she did have syncopal episode < 3 mn ago Cardiology consulted, sinus brady has been present for several yrs Pt is stable for discharge      Generalized weakness In the setting of above Consult PT/OT   Essential hypertension On amlodipine, losartan and hydrochlorothiazide Cont current home medications   Hypothyroidism Continue Synthroid, TSH .47    Chronic pain syndrome NARx reviewed Continue hydrocodone/acetaminophen  Hyperlipidemia Continue statins   Depression Continue Lexapro   GERD Continue PPI
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sinus bradycardia, Sinus rhythm, Syncope
Clinical narrative: Patient is a 79 y.o. female patient of local MD with history of COPD, hypothyroidism, chronic pain syndrome, essential hypertension, hyperlipidemia presented to ED with shortness of breath.  Found to have COVID-19 infection with acute hypoxic respiratory failure and AKI .  Patient transferred to Doctors Hospital for further medical care.   Covid-19 Virus Infection Acute hypoxic respiratory failure Acute COPD exacerbation Date of onset of symptoms: 1-2 days Symptoms present on admission: URI symptoms including cough, shortness of breath Date of covid positive test: 02/7/23 Vaccination status: vaccinated Imaging: Chest x-ray with bibasilar opacities Oxygen requirements on admission: 2L  Current oxygen requirements: 2L Medical therapy: dexamethasone Consultants following: None Anticipated special isolation end date: 02/16/23 Hypoxia has resolved, pt is stable for discharge     AKI 1.45 on admission at hospital Received IV fluid hydration, AKI resolved, Cr .75   Sinus bradycardia HR in 39-84, sinus rhythm, TTE: EF 55% Mostly asymptomatic, but states she did have syncopal episode < 3 mn ago Cardiology consulted, sinus brady has been present for several yrs Pt is stable for discharge      Generalized weakness In the setting of above Consult PT/OT   Essential hypertension On amlodipine, losartan and hydrochlorothiazide Cont current home medications   Hypothyroidism Continue Synthroid, TSH .47    Chronic pain syndrome NARx reviewed Continue hydrocodone/acetaminophen  Hyperlipidemia Continue statins   Depression Continue Lexapro   GERD Continue PPI
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Tinnitus
Clinical narrative: Very noticeable, persistent tinnitus started since day after received 2nd dose.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling, Peripheral swelling, Pruritus, Rash, Skin warm
Clinical narrative: Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: swelling left arm to elbow. pt states itches and warm to touch-Mild
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Contusion, Erythema, Headache, Induration
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Headache-Mild, Additional Details: patient came to pharmacy 2/3/23, indicating a hard bruise,redness,itching at the site,tenderness at site,chills and headache. redness was around the site of injection on left arm. patient said redness was getting better but she was concerned
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Chills-Mild, Systemic: Headache-Mild, Additional Details: patient came to pharmacy 2/3/23, indicating a hard bruise,redness,itching at the site,tenderness at site,chills and headache. redness was around the site of injection on left arm. patient said redness was getting better but she was concerned
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injury associated with device
Clinical narrative: Error: Patient Accidentally Stuck by Needle-
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, Chest X-ray normal, Fatigue, Hypophagia
Clinical narrative: Patient admitted for fatigue and AKI thought to be due to COVID infection and poor oral intake. She was started on IVF hydration with resolution of AKI. Patient remains on room air without resp symptoms of COVID. She is stable for discharge home an encouraged to increase oral intake and ensure hydration.    Clinical Summary   Assessment and Plan Patient is a 66 y.o. female patient of DO with history of mitral regurgitation status post mitral valve replacement, valvular atrial fibrillation, hyperlipidemia, anxiety, hypothyroidism, hypertension, GERD, and CKD stage III.  She is admitted as a transfer from freestanding for AKI and fatigue in the setting of recent COVID diagnosis.   AKI-resolved Metabolic acidosis-resolved Suspect most likely prerenal in the setting of COVID-19 and decreased intake.  Continue IV fluids-change to bicarb infusion Avoid nephrotoxins Held home hydrochlorothiazide and lisinopril S/P IVF   Covid-19 Virus Infection Date of onset of symptoms: 2/5/2023 Symptoms present on admission: Malaise Date of covid positive test: 2/6/2023 Vaccination status: Only received Johnson & Johnson vaccine Imaging: Chest x-ray 2/9/2023 unremarkable Oxygen requirements on admission: None Current oxygen requirements: None Medical therapy: Not indicated Anticipated special isolation end date: 2/14/2023  Hypertension Held home lisinopril and hydrochlorothiazide in the setting of AKI  Held home diltiazem in the setting of soft BPs on admission and poor intake Continue home metoprolol Restart BP meds when able DC back on home meds  Mitral valve insufficiency status post replacement Valvular atrial fibrillation Continue home Coumadin (takes 3 mg daily) INR goal 2.5-3.5, pharmacy to dose Continue home metoprolol and holding home diltiazem as above  GERD Continue PPI  Hypothyroidism Continue home Synthroid
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Malaise, Metabolic acidosis, SARS-CoV-2 test positive
Clinical narrative: Patient admitted for fatigue and AKI thought to be due to COVID infection and poor oral intake. She was started on IVF hydration with resolution of AKI. Patient remains on room air without resp symptoms of COVID. She is stable for discharge home an encouraged to increase oral intake and ensure hydration.    Clinical Summary   Assessment and Plan Patient is a 66 y.o. female patient of DO with history of mitral regurgitation status post mitral valve replacement, valvular atrial fibrillation, hyperlipidemia, anxiety, hypothyroidism, hypertension, GERD, and CKD stage III.  She is admitted as a transfer from freestanding for AKI and fatigue in the setting of recent COVID diagnosis.   AKI-resolved Metabolic acidosis-resolved Suspect most likely prerenal in the setting of COVID-19 and decreased intake.  Continue IV fluids-change to bicarb infusion Avoid nephrotoxins Held home hydrochlorothiazide and lisinopril S/P IVF   Covid-19 Virus Infection Date of onset of symptoms: 2/5/2023 Symptoms present on admission: Malaise Date of covid positive test: 2/6/2023 Vaccination status: Only received Johnson & Johnson vaccine Imaging: Chest x-ray 2/9/2023 unremarkable Oxygen requirements on admission: None Current oxygen requirements: None Medical therapy: Not indicated Anticipated special isolation end date: 2/14/2023  Hypertension Held home lisinopril and hydrochlorothiazide in the setting of AKI  Held home diltiazem in the setting of soft BPs on admission and poor intake Continue home metoprolol Restart BP meds when able DC back on home meds  Mitral valve insufficiency status post replacement Valvular atrial fibrillation Continue home Coumadin (takes 3 mg daily) INR goal 2.5-3.5, pharmacy to dose Continue home metoprolol and holding home diltiazem as above  GERD Continue PPI  Hypothyroidism Continue home Synthroid
Age: 44.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Asthma, Atelectasis, COVID-19
Clinical narrative: Patient is a 28 y.o. female patient of CNP with history of asthma, anemia, presented to local Medical Center with shortness of breath.   Covid-19 Virus Infection Multifocal pneumonia  Date of onset of symptoms: Before 2/1. Symptoms present on admission: Cough, congestion, shortness of breath Date of covid positive test: 2/7 Vaccination status: vaccinated Imaging: CTPA shows multifocal GGO likely infectious vs inflammatory process, no PE Baseline oxygen requirements prior to admission: Room air Current oxygen requirements: Required 6 L on admission, now on 2L  Medical therapy: remdesivir and steroids Consultants following: Pulmonology Anticipated special isolation end date: 2/11 if symptom onset truly started before 2/1   Acute respiratory failure with hypoxia-resolved Acute Asthma exacerbation  VCD (Vocal Cord Dysfunction) Likely exacerbated by COVID (see above)  Hypoxic and requiring 6 L/min with a baseline of RA CT showed multifocal GGO likely infectious vs inflammatory process, no PE Duonebs, and steroids On RA at rest and on ambulation 2/10 Pulm following   Right middle lobe atelectasis Noted on CT Repeat CT chest in 6 to 8 weeks   OSA Cpap per RT
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Inflammation, Lung opacity
Clinical narrative: Patient is a 28 y.o. female patient of CNP with history of asthma, anemia, presented to local Medical Center with shortness of breath.   Covid-19 Virus Infection Multifocal pneumonia  Date of onset of symptoms: Before 2/1. Symptoms present on admission: Cough, congestion, shortness of breath Date of covid positive test: 2/7 Vaccination status: vaccinated Imaging: CTPA shows multifocal GGO likely infectious vs inflammatory process, no PE Baseline oxygen requirements prior to admission: Room air Current oxygen requirements: Required 6 L on admission, now on 2L  Medical therapy: remdesivir and steroids Consultants following: Pulmonology Anticipated special isolation end date: 2/11 if symptom onset truly started before 2/1   Acute respiratory failure with hypoxia-resolved Acute Asthma exacerbation  VCD (Vocal Cord Dysfunction) Likely exacerbated by COVID (see above)  Hypoxic and requiring 6 L/min with a baseline of RA CT showed multifocal GGO likely infectious vs inflammatory process, no PE Duonebs, and steroids On RA at rest and on ambulation 2/10 Pulm following   Right middle lobe atelectasis Noted on CT Repeat CT chest in 6 to 8 weeks   OSA Cpap per RT
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Pneumonia, Positive airway pressure therapy, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Patient is a 28 y.o. female patient of CNP with history of asthma, anemia, presented to local Medical Center with shortness of breath.   Covid-19 Virus Infection Multifocal pneumonia  Date of onset of symptoms: Before 2/1. Symptoms present on admission: Cough, congestion, shortness of breath Date of covid positive test: 2/7 Vaccination status: vaccinated Imaging: CTPA shows multifocal GGO likely infectious vs inflammatory process, no PE Baseline oxygen requirements prior to admission: Room air Current oxygen requirements: Required 6 L on admission, now on 2L  Medical therapy: remdesivir and steroids Consultants following: Pulmonology Anticipated special isolation end date: 2/11 if symptom onset truly started before 2/1   Acute respiratory failure with hypoxia-resolved Acute Asthma exacerbation  VCD (Vocal Cord Dysfunction) Likely exacerbated by COVID (see above)  Hypoxic and requiring 6 L/min with a baseline of RA CT showed multifocal GGO likely infectious vs inflammatory process, no PE Duonebs, and steroids On RA at rest and on ambulation 2/10 Pulm following   Right middle lobe atelectasis Noted on CT Repeat CT chest in 6 to 8 weeks   OSA Cpap per RT
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Error: Expired Product Administered-
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Condition aggravated, Cough, Electrocardiogram normal
Clinical narrative: Patient is a 95 y.o. male patient of MD with history of dementia, TIA, urinary incontinence, HTN, prostate CA who presented to Hospital with weakness and cough.    COVID 19 Virus Infection Generalized Weakness Suspect weakness due to underlying COVID in this 95yo Started on Paxlovid as per ID recs Gentle IVF PT/OT Supportive Care   Elevated Troponin Chronically elevated Pt without chest pain EKG with no ischemic changes   Hypertension Blood pressure has been elevated while here in he hospital.  Wife is reluctant to start on anti hypertensive. Prescribed atenolol on discharge. Wife states she will check his blood pressure at home and give medication if it is high.
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Troponin increased
Clinical narrative: Patient is a 95 y.o. male patient of MD with history of dementia, TIA, urinary incontinence, HTN, prostate CA who presented to Hospital with weakness and cough.    COVID 19 Virus Infection Generalized Weakness Suspect weakness due to underlying COVID in this 95yo Started on Paxlovid as per ID recs Gentle IVF PT/OT Supportive Care   Elevated Troponin Chronically elevated Pt without chest pain EKG with no ischemic changes   Hypertension Blood pressure has been elevated while here in he hospital.  Wife is reluctant to start on anti hypertensive. Prescribed atenolol on discharge. Wife states she will check his blood pressure at home and give medication if it is high.
Age: 96.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (ex. temp./location)-
Age: 74.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Injection site pain, Neck pain, Pain, Pain in extremity
Clinical narrative: Site: Pain at Injection Site-Severe, Additional Details: Pt. had pain at injection site. Pain radiated to shoulder/arm/neck. Pain not relieved by cyclobenzaprine. Pt. referred to ER for further check up as per pt's daughter.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19-2, COVID19-2, COVID19-2
Symptoms: Asthenia, Mobility decreased, Pain in extremity, X-ray normal
Clinical narrative: My arm starting hurting the next day and it has not stopped since. I can feel the exact spott the shot ws give when I move my arm. It has now been 4 months and I never had a reaction to any of the other injections. I went Urgent Care on 01/09/2023 My right arm was X-Rayed it did not show anything. The PA gave me some arm strengthening exercises to do, however that has not helped. This is not normal I feel like I have lost strength and mobility in it.
Age: 54.0
Sex: F
Vaccine: FLU4, HEP
Symptoms: Dizziness, Headache, Posture abnormal
Clinical narrative: At 0958 hrs, after vaccinating patient ( 54 Y/O female), with Hepatitis B and Influenza, patient slumped in chair but did not lose consciousness.  Patient reported feeling dizzy with headache 6/10; patient also reported history of headaches. LVN took VS at 100:00 am and were BP165/90, HR 79. Patient then reported she had been fasting since 2/27/2023. She was offered Emergency Medical Services but denied them. She denied previous vaccine reaction to vaccines and major health issues. At 10:05 am VS were BP 158/81, HR 79. Patient then stated headache pain level to be 4/10. PHN Supervisor was notified of the situation. 10:20 am VS were 161/77, HR 79. At this time, patient reported that the dizziness and headache diminished. Final VS 10:35 am were BP 124/76, HR 63. Patient remained alert and oriented through the entire event.  LVN advised patient to follow up with PCP and for husband to observe for any changes in condition. 10:50 AM pATIENT DEPARTED CLINIC WITH HUSBAN.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site swelling, Lymphadenopathy
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Lymph Node Swelling-Severe, Additional Details: patient complains of lymphnode swelling in left armpit. size of swelling = golfball
Age: 60.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Interstitial lung disease
Clinical narrative: Acute Interstitial Pneumonia
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Injection site pain, Insomnia
Clinical narrative: Systemic: Joint Pain-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Unable to Sleep-Severe, Additional Details: Paitent states that he got the vaccine on 09/30/2021 in the right shoulder, He started feeling the following symptoms ( right shoulder pain, loss of motion, numbness, difficulty sleeping) till the day of this report ( 495 days) Patient states that he was following up with his primary care physician then referred to MD care. Patient states that he has been going to physical therapy 2 time a week till the day of this report.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cartilage injury, Insomnia, Magnetic resonance imaging, Mobility decreased, Muscle atrophy
Clinical narrative: Systemic: Joint Pain-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Unable to Sleep-Severe, Additional Details: Paitent states that he got the vaccine on 09/30/2021 in the right shoulder, He started feeling the following symptoms ( right shoulder pain, loss of motion, numbness, difficulty sleeping) till the day of this report ( 495 days) Patient states that he was following up with his primary care physician then referred to MD care. Patient states that he has been going to physical therapy 2 time a week till the day of this report.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Nerve injury, Pain, Periarthritis, Rotator cuff syndrome
Clinical narrative: Systemic: Joint Pain-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Unable to Sleep-Severe, Additional Details: Paitent states that he got the vaccine on 09/30/2021 in the right shoulder, He started feeling the following symptoms ( right shoulder pain, loss of motion, numbness, difficulty sleeping) till the day of this report ( 495 days) Patient states that he was following up with his primary care physician then referred to MD care. Patient states that he has been going to physical therapy 2 time a week till the day of this report.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Wrong Age for Vaccine Given-
Age: 65.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered
Clinical narrative: Pt was in Clinic at the Health Department.  Our system report she only had one dose of Hep A.  A second dose was administered to her at the visit.  It was then discovered that the Health department had administered a second dose already 6 months previously.  It had been administered during a period of time when a new electronic medical records system was installed and the vaccine had not been pushed to system.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Autoimmune disorder, Blood glucose increased, Blood test, Glycosylated haemoglobin
Clinical narrative: Got pregnant 2 weeks later and miscarried at 7 weeks due to high glucose levels due to an autoimmune response of type 1 diabetes that was not diagnosed until June 17th, 2022
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure before pregnancy, Pregnancy, Type 1 diabetes mellitus
Clinical narrative: Got pregnant 2 weeks later and miscarried at 7 weeks due to high glucose levels due to an autoimmune response of type 1 diabetes that was not diagnosed until June 17th, 2022
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Site: Swelling at Injection Site-Medium, Additional Details: PATIENT STATED THAT SHE HAD A SORE ARM AT THE INJECTION SITE SINCE 1/18/23 OF IMMUNIZATION.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Paraesthesia, Paraesthesia oral
Clinical narrative: Tingling in my entire body, started with hands and feet, then arms and legs, then face and mouth
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Arthralgia, Autonomic nervous system imbalance, Bladder dysfunction, Blood test
Clinical narrative: I immediately was sick. The fluid entered and it felt like it traveled. The feeling was like bees stinging me. My arm swelled right away. I was kept for forty five minutes to ensure no swelling of mouth. Went home. Within hours could not walk. My joints were so painful. Rash. 105 temperature. Called Public Health and was told ALL NORMAL. After ten days I was better but not great. I could participate in life but my bladder was not working and I just hurt. Three weeks later at 8:30pm it all came rushing back. The bees stinging. The rash. My chest was on fire.My heart raced. The internal vibrations were overwhelming.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, Chest pain, Gait inability, Imaging procedure, Immediate post-injection reaction
Clinical narrative: I immediately was sick. The fluid entered and it felt like it traveled. The feeling was like bees stinging me. My arm swelled right away. I was kept for forty five minutes to ensure no swelling of mouth. Went home. Within hours could not walk. My joints were so painful. Rash. 105 temperature. Called Public Health and was told ALL NORMAL. After ten days I was better but not great. I could participate in life but my bladder was not working and I just hurt. Three weeks later at 8:30pm it all came rushing back. The bees stinging. The rash. My chest was on fire.My heart raced. The internal vibrations were overwhelming.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Pain, Palpitations, Peripheral swelling, Postural orthostatic tachycardia syndrome
Clinical narrative: I immediately was sick. The fluid entered and it felt like it traveled. The feeling was like bees stinging me. My arm swelled right away. I was kept for forty five minutes to ensure no swelling of mouth. Went home. Within hours could not walk. My joints were so painful. Rash. 105 temperature. Called Public Health and was told ALL NORMAL. After ten days I was better but not great. I could participate in life but my bladder was not working and I just hurt. Three weeks later at 8:30pm it all came rushing back. The bees stinging. The rash. My chest was on fire.My heart raced. The internal vibrations were overwhelming.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Sensory disturbance, Vibratory sense increased
Clinical narrative: I immediately was sick. The fluid entered and it felt like it traveled. The feeling was like bees stinging me. My arm swelled right away. I was kept for forty five minutes to ensure no swelling of mouth. Went home. Within hours could not walk. My joints were so painful. Rash. 105 temperature. Called Public Health and was told ALL NORMAL. After ten days I was better but not great. I could participate in life but my bladder was not working and I just hurt. Three weeks later at 8:30pm it all came rushing back. The bees stinging. The rash. My chest was on fire.My heart raced. The internal vibrations were overwhelming.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injury
Clinical narrative: I immediately was sick. The fluid entered and it felt like it traveled. The feeling was like bees stinging me. My arm swelled right away. I was kept for forty five minutes to ensure no swelling of mouth. Went home. Within hours could not walk. My joints were so painful. Rash. 105 temperature. Called Public Health and was told ALL NORMAL. After ten days I was better but not great. I could participate in life but my bladder was not working and I just hurt. Three weeks later at 8:30pm it all came rushing back. The bees stinging. The rash. My chest was on fire.My heart raced. The internal vibrations were overwhelming.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Accidental improper storage of vaccine leading to temperature excursion prior to vaccine administration
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Glaucoma, Ocular discomfort, Optic nerve injury, Vision blurred
Clinical narrative: Blurriness in left eye, rapid increase in eye pressure,  damaged optic nerves,  diagnosed with glaucoma,        all occurred within six months of the vaccines.
Age: 25.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received vaccine past beyond use date. No adverse effects reported
Age: 26.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Product use issue
Clinical narrative: Patient received vaccine beyond use date - no adverse effects reported
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received vaccination past beyond use date - no adverse effects reported
Age: 35.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was administered Pfizer Bivalent Vaccine instead of Pfizer Monovalent.
Age: 76.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: on 11/23/22 and 1/24/23 patient received 2 unindicated bivalent boosters.  When he came in to request another booster we noticed he had already received 2 additional boosters on the dates listed. We are reporting the 2 additional boosters received that were not indicated on 11/23/22 and 1/24/23. The patient did not report any side effects or issues after receiving the additional boosters.
Age: 46.0
Sex: F
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient had already received a dose of Heplisav-B earlier that day and due to communication issues, a dose of Engerix-B was also given the same day.  Patient wanted Varivax which she did receive as well after we figured out she didn't need Engerix-B from my store.  Patient had no signs of any adverse reactions or symptoms.
Age: 55.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Cerebrovascular accident, Computerised tomogram head normal, Magnetic resonance imaging head abnormal
Clinical narrative: I had a combination COVID-19 and flu vaccination at 8 pm on Friday. At 2 pm on Saturday, I had a stroke.
Age: 41.0
Sex: F
Vaccine: COVID19-2, DTAP
Symptoms: Ear discomfort, Ear pain, Tinnitus
Clinical narrative: Clogged left ear with intermittent severe pain and constant hissing sound
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt had second Pfizer covid 19 mono valent vaccine given on 01/26/2023 In office yesterday received Pfizer Covid 19 BIVALENT was supposed to be 2 months from the second doses therefore given too soon parent aware returning in 2 months for Covid 19 Bivalent booster
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: On 1/11/23 (1 day after vaccines), patient developed large area of redness and swelling in left arm along with pain . Mom advised to treat with compresses and give tylenol and advil for pain. Mom notes on 1/13/23 symptoms improving. Mom states symptoms took 1 week to resolve in total
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Janssen COVID-19 Vaccine to 17 year old patient at discharge from hospital on 9/4/21.  Per report she was called by provider on 10/4/21.  Provider notes state "Called patient, I discussed the Covid 19 vaccine that she she received inpatient.  It was Johnson and Johnson, which has not been okayed to be given to persons under the age of 17yo, at the time she received the vaccine, she was 2 months away from turning 18 yo.  There is a lack of research on person's under 18 yo.  There is a very small risk of blood clot formation, she reports no adverse side effects from the vaccine.  She missed her postpartum visit, I gave her the number to call to schedule her PPV, and encouraged her to do so.  I apologized on behalf of the staff at the facility for this mistake, she had no further questions. "